Sunfish Partners

📢We are happy to share that Aether Biomedical has been awarded 1st place in the #TheBestBit competition, held during the Lem Festival, a celebration of science inspired by the legacy of Stanisław Lem, the renowned Polish sci-fi visionary, and organized by Instytut Lema.🎉 From hundreds of innovative startups, We made it to the "Top 10 Finalists" and ultimately achieved the top prize.🦾🏆🥇 🫂A special thanks to the Competition Committee:  - Dr Maciej Kawecki, President of Instytut Lema  - Dariusz Piotrowski , GM of Dell Technologies  - Mateusz Sipa, Director at Invest in Lodz (Central Poland)  - Adrian Kulesza, Head of Marketing EC1 Łódź - Miasto Kultury w Łodzi Łódź   - Jakub Rawski, Head of Innovation Center Uniwersytet WSB Merito Warszawa This special event was made possible through the support of Instytut Lema, co-organized by #CentrumInnowacji Uniwersytet WSB Merito Warszawa, and sponsored by the Ministry of Science and Higher Education. We’re thankful for this recognition and remain committed to pushing the boundaries of science and technology. Thank you to everyone who supported and believed in us—we couldn’t have done it without you!💙 #Innovation #Science #AssistiveTechnology #LemFestival #AetherBiomedical #TheBestBit #Zeus #Zeushand

🚀 Unlocking the Potential of Real-World Data in clinical trials In the latest episode of Trials with Maya Z, our CTO Jan Poleszczuk dives deep into the challenges and opportunities of Real-World Data (#RWD) in healthcare. From his journey as a mathematician turned healthcare innovator to his work at CliniNote, Jan shares how we empower doctors to generate high-quality data while simplifying their workflows. 🎯 Key insights from the episode: - The biggest roadblocks to RWD quality—and how to tackle them - The critical role of medical notes in creating actionable Real-World Data. - How CliniNote’s automation tools are transforming doctors' workflows and driving better outcomes - A vision for the future of RWD in clinical trials and beyond Join us as we explore the good, the bad, and the future of RWD—and how innovation is reshaping healthcare. 🎧 Don’t miss this thought-provoking conversation with Maya Zlatanova! #HealthcareInnovation #RWD #CliniNote

Our mission is simple but vital: to enable athletes, both professional and amateur, to train and develop without limits through responsible preventive health care 🏅 At Smarter Diagnostics, we focus on the long-term health and fitness of athletes, combining the latest technological advances with medical expertise to create a safer environment for training and performance. Why we do it? We believe that athletic longevity is not only a matter of physical health, but also of pursuing passions and achieving goals at every stage of life. Too often, athletes, regardless of their level, encounter injuries that can derail their plans. Our goal is to change this attitude. Through our technology - advanced MRI, AI analysis, and comprehensive reporting - we are able to provide data that helps identify and manage risk factors even before a problem occurs. How we work? Smarter Diagnostics develops technologies that support not only injury prevention, but also sports longevity. We offer advanced diagnostic tests that allow coaches and athletes to monitor health and optimize training programs. Our solutions are based on artificial intelligence, which analyzes test results and allows us to tailor them to the unique needs of each athlete, increasing the efficiency and safety of training. Why support us? This innovative approach is already receiving a lot of attention in the HealthTech and sports market, and the demand for prevention and support of sports longevity continues to grow. We are ready, with the help of investors, to expand our business into more markets and offer our solutions to an ever wider audience. Together with us, you can become part of a revolution that is changing the way we think about health in sports, affecting not only individuals, but also entire sports teams and environments. When you invest in Smarter Diagnostics, you are investing in the future of athlete health, in technology with broad scaling potential, and in the sustainability of our company, which is focused on long-term value. Sports Longevity Smarter Diagnostics Invest in Value Health Tech AI in Sports Injury Prevention

We're excited to announce that molecule.one has made it to the final phase of the Standard Industries Chemical Innovation Challenge! In this next stage, we'll be showcasing our AI-driven approach to retrosynthesis, competing for the $1M grand prize and a chance to collaborate with W. R. Grace to advance materials science. We're thrilled to be part of this challenge and look forward to continuing the work that will shape the future of chemical discovery. At molecule.one, we believe successful retrosynthesis is key to successful synthesis. By training our AI models with high-quality reactivity data from our own high-throughput lab, we optimize pathways and predict outcomes more accurately. This enables us to create diverse virtual focus screening libraries and rapidly synthesize them, accelerating compound development with precision and speed. Interested in advancing your retrosynthesis or exploring how our screening libraries can help? Let's connect and explore the possibilities: https://lnkd.in/dfWzXemw #StandardInnovationChallenge #AIinChemistry #Retrosynthesis #Innovation #ChemicalDiscovery

I will have a pleasure to lead a discussion about “Bridging the Gap: Streamlining clinical practice and research with technology” at the DigiOne i3 project on the 27th of Nov at 3:00 PM.    See you soon in Utrecht!   #Digicore #digitalhealth #RWE #RWD #Oncology #clinicaltrials

On-track to deliver propulsion system in less than 3 months. Perhaps an industry record time. 😎 The tanks passed all the checks prior to the system assembly. They’re heading to space soon! 🔜

Just in case you are asking yourself why we at Sunfish Partners are so focused on investing in CEE. We think that these markets are still hugely underrated from a venture capital point of view ("traditional" private equity has been significantly faster to capitalize on this opportunity). Just see for yourself... These numbers are taken from the "Autumn 2024 Economic Forecast" just release by the EU (https://lnkd.in/e-ArJWtY)

We are investing in tech startups in CEE (mainly Poland) for over 5 years now and - to this day - many people have not realized the enormous opportunity this region presents. If you have, talk to us ;-).

Deepflare, which optimizes antigen design in vaccine development, is our portfolio spotlight of the month. 💥 The team helps pharmaceutical companies create previously impossible vaccines. Their slogan is “Lightning up the vaccine discovery process.” 💥They collaborate with pharmaceutical and biotechnology companies across the US, UK, Europe, and Asia. The team has already secured multiple large deals with clients, assisting them in developing therapies for previously incurable targets using their proprietary platform for in silico epitope discovery. 💥Deepflare has also published papers demonstrating the superiority of its technology and recently validated the platform’s effectiveness in an in vivo study on mice. A paper on this study will be published early next year. 💥By optimizing immunogenicity, they are helping to ensure a safer future for all of us with next-generation vaccines and immunotherapies for cancer, viruses, and other diseases. Learn more about them at https://www.deepflare.ai/ or by contacting the founders, Piotr Grzegorczyk, Grzegorz Preibisch, and Stanisław Giziński.

If you're going to Space Tech Expo Europe, make sure to save the date! Tomasz Palacz, the CEO of Liftero, will be sharing insights on our company, satellite propulsion systems, and future plans on the Industry Stage. 🔥 📆 20 November 2024 🕚 11:10 am - 12:10 pm 📍 MESSE Bremen Exhibition Hall 5, Industry Stage See you there! Psst… Want to chat with Tomasz in person? Just drop him a message on LinkedIn. 😉 #SpaceTechExpo #cassiniEU #EUSpace #Startup